Von Hippel-Lindau Disease

Czech version

Authors: P. Plevová ¹; J. Novotný ²; A. Křepelová ³
Authors‘ workplace: Ústav patologie & Laboratoř molekulární patologie LF UP Olomouc 2Institut onkologie a rehabilitace Na Pleši s. r. o., Nová Ves pod Pleší 3Ústav biologie a lékařské genetiky FN Motol a 2 LF UK Praha ; Oddělení lékařské genetiky FN Ostrava ¹
Published in: Klin Onkol 2009; 22(Supplementum): 23-24

Sources

1. Glasker S, Bender BU, Apel TW et al. The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system. J Neurosurg Psychiatry 1999; 67: 758–762.

2. Hes F, Zewald R, Peeters T et al. Genotyp-phenotype correlation in families with deletions in the von Hippel-Lindau gene. Human Genet 2000; 106: 423–431.

3. http://www.mdanderson.org/diseases/vhl/ (Texaská univerzita, MD Anderson Cancer Center).

4. Lindor NM, Greene MH a Mayo Familial Cancer Program. The concise handbook of family cancer syndromes. J Natl Cancer Inst 1998; 90: 1067–1068.

5. Maher ER, Kaelin WG. Von Hippel-Lindau Disease. Medicine 1997; 76: 381–391.

6. www.vhl.org (Massachusetts General Hospital Cancer Center)